Comparison of the Prognostic Prediction Capabilities of Different Comorbidity Indices in Elderly Peritoneal Dialysis Patients

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Comparison of the Prognostic Prediction Capabilities of Different Comorbidity Indices in Elderly Peritoneal Dialysis Patients

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Sheng
Feng
Sheng Feng f.sh@hotmail.com The Second affiliated Hospital of Soochow university Nephrology Suzhou China *
Huaying Shen shenhy513@sina.com The Second affiliated Hospital of Soochow university Nephrology Suzhou China -
 
 
 
 
 
 
 
 
 
 
 
 
 

This study aims to explore the optimal comorbidity index for predicting adverse outcomes in elderly peritoneal dialysis (PD) patients and to construct, evaluate, and validate the best risk prediction model for assessing mortality and technical failure rates in this population. Through precise risk assessment, this research aims to assist clinicians in the timely and efficient identification of the risks of mortality and technical failure faced by patients. 

This study is a retrospective cohort study that includes elderly peritoneal dialysis (PD) patients aged ≥65 years (N = 411) who were registered and regularly followed up at the Peritoneal Dialysis Center of the Second Affiliated Hospital of Soochow University between January 1, 2009, and December 31, 2023, with follow-up extending until June 30, 2024. Initially, univariate and multivariate Cox regression analysis were performed to screen variables significantly associated with survival and technical survival. The final optimal prediction model was established, with calibration curves plotted to evaluate its goodness of fit and a nomogram constructed. Internal and external validation of the predictive model were subsequently performed.

This study included 411 elderly peritoneal dialysis (PD) patients who met the inclusion criteria. Fifty patients were excluded due to a peritoneal dialysis duration of less than 3 months, renal function recovery, kidney transplantation, or loss to follow-up, leaving 328 patients in the final analysis. Among these, 190 patients (57.9%) died, 52 patients (15.9%) transitioned from peritoneal dialysis to hemodialysis, and 86 patients (26.2%) remained on peritoneal dialysis at the end of the follow-up. Univariate analysis of the training cohort identified nine potential risk factors for mortality and technical failure in elderly PD patients (P < 0.05). Lasso regression analysis further narrowed down the risk factors to seven, indicating that age, hemoglobin, serum phosphate, serum albumin, CDMF-CCI, EVCI, and the Taiwan Index were all significant risk factors for mortality and technical failure in elderly PD patients. The results showed that age, serum albumin, and the three comorbidity indices (CDMF-CCI, EVCI, Taiwan Index) were independent risk factors for mortality and technical failure (P < 0.05). The study constructed a base model using age and serum albumin as variables, and single-factor comorbidity models using CDMF-CCI, EVCI, and the Taiwan Index separately. We then built a multivariate Cox prediction model by combining all three comorbidity indices with the base model. Time-dependent ROC curves were plotted for 1-year, 3-year, 5-year, 8-year, and 10-year survival, and the AUC, NRI, and IDI were compared for all seven prediction models. The results showed that the single-factor comorbidity models were less accurate than the base model in predicting both mortality and technical failure rates in elderly PD patients. However, after adding the comorbidity indices to the base model, we found that the prediction accuracy of all multivariate Cox prediction models improved to varying extents. The multivariate Cox model combining CDMF-CCI with age and serum albumin demonstrated the best performance, especially in predicting mid-term survival and technical survival rates, showing a significant improvement in prediction accuracy. Based on comparisons of different combinations, we selected the model with the best predictive performance for mortality and technical failure in elderly PD patients, which was the multivariate Cox model comprising CDMF-CCI, age, and serum albumin. A Nomogram and calibration curve were generated for this model, and the calibration curve showed good consistency between the observed and predicted probabilities.

Table 1. Comparison of baseline characteristics in elderly PD patients in the survival and death groups

 

Survival group(N=138)

death group(N=190)

P

Age(years)

69(66~74)

74(70~78)

<0.001

Dialysis vintage(months)

28.5(17.0~53.0)

28.0(16.0~52.0)

0.545

Gender(n,%)

     Male

     Female

 

83(60.1%)

55(39.9%)

 

99(52.1%)

91(47.9%)

0.148

BMI(kg/m²)

21.97(20.39~23.80)

21.50(19.60~23.80)

0.214

HGB(g/L)

112.5±22.6

114.4±67.2

0.466

PLT(×109/L)

179.5(136.0~223.0)

169.0(135.0~218.0)

0.226

Ca(mmol/L)

2.12(1.98~2.22)

2.11(1.95~2.23)

0.471

P(mmol/L)

1.37(1.17~1.61)

1.28(1.07~1.52)

0.011

Cr(μmol/L)

577.0(479.0~655.0)

506.5(405.0~677.0)

0.027

BUN(mmol/L)

17.5±5.2

16.5±5.2

0.082

ALB(g/L)

32.4±5.9

30.7±5.8

0.012

Kt/v

1.78(1.55~2.05)

1.79(1.54~2.08)

0.773

Episodes  of peritonitis(n,%)

50(36.2%)

83(43.7%)

0.175

CDMF-CCI

4.0(3.0~5.0)

5.0(4.0~6.0)

<0.001

EVCI

9.0(8.0~19.0)

18.0(8.0~21.0)

0.001

Taiwan index

3.0(0.0~6.0)

5.0(3.0~7.0)

<0.001

Table 2. Time-dependent AUC and Comparative Model Results for Mortality in Elderly Peritoneal Dialysis Patients

Models

 

 

T=1年

T=3年

T=5年

T=8年

 

M1

 

AUC

(95%CI)

P

0.67

(0.58~0.77)

-

0.77

(0.71~0.83)

-

0.79

(0.72~0.86)

-

0.81

(0.72~0.90)

-

 

M2

 

AUC

(95%CI)

P

0.74

(0.66~0.82)

0.060

0.81

(0.76~0.86)

0.038

0.84

(0.78~0.90)

0.011

0.89

(0.82~0.95)

0.014

 

M3

 

AUC

(95%CI)

P

0.70

(0.61~0.79)

0.219

0.76

(0.70~0.82)

0.365

0.82

(0.76~0.88)

0.065

0.84

(0.76~0.92)

0.282

 

M4

 

AUC

(95%CI)

P

0.75

(0.67~0.83)

0.013

0.77

(0.71~0.83)

0.883

0.82

(0.75~0.88)

0.212

0.85

(0.78~0.93)

0.172

M1:age+ALB;M2: M1+CDMF-CCI;M3:M1+EVCI;M4:M1+Taiwan index;



1.  Age, serum albumin, as well as CDMF-CCI, EVCI, and the Taiwan Index, are independent risk factors for mortality and technical failure in elderly peritoneal dialysis (PD) patients.

2.  Among the three comorbidity indices, CDMF-CCI demonstrates the best predictive performance for adverse outcomes in elderly PD patients.

3.  The composite model consisting of CDMF-CCI, age, and serum albumin shows the optimal predictive performance and can serve as a prognostic tool to guide clinicians in treatment decision-making.

Kewords